Insider Selling: Cabot (NYSE:CBT) CEO Sells 2,779 Shares of Stock

Cabot Corporation (NYSE:CBT) CEO Sean Keohane sold 2,779 shares of Cabot stock in a transaction dated Monday, August 24th. The shares were sold at an average price of $85.50, for a total value of $237,604.50. Following the completion of the transaction, the chief executive officer directly owned 288,873 shares of the company’s stock, valued at $24,698,641.50. This represents a 0.95% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website.

Cabot Price Performance

Shares of CBT traded up $0.75 during mid-day trading on Wednesday, hitting $84.39. 110,808 shares of the company traded hands, compared to its average volume of 472,356. The business has a 50-day moving average of $87.99 and a 200 day moving average of $81.05. Cabot Corporation has a one year low of $58.33 and a one year high of $94.53. The company has a current ratio of 1.47, a quick ratio of 0.97 and a debt-to-equity ratio of 0.48. The stock has a market capitalization of $4.36 billion, a price-to-earnings ratio of 23.77, a PEG ratio of 10.89 and a beta of 0.84.

Cabot (NYSE:CBT) last released its earnings results on Monday, August 3rd. The specialty chemicals company reported $1.67 EPS for the quarter, beating the consensus estimate of $1.66 by $0.01. The company had revenue of $982.00 million during the quarter, compared to analysts’ expectations of $943.16 million. Cabot had a return on equity of 20.29% and a net margin of 5.23%.The business’s revenue for the quarter was up 6.4% on a year-over-year basis. During the same period last year, the firm earned $1.90 EPS. Cabot has set its FY 2026 guidance at 6.150-6.450 EPS. As a group, equities analysts expect that Cabot Corporation will post 6.37 earnings per share for the current fiscal year.

Cabot Dividend Announcement

The firm also recently announced a quarterly dividend, which will be paid on Friday, September 11th. Shareholders of record on Friday, August 28th will be issued a dividend of $0.4725 per share. This represents a $1.89 dividend on an annualized basis and a yield of 2.2%. The ex-dividend date of this dividend is Friday, August 28th. Cabot’s payout ratio is currently 53.24%.

Analysts Set New Price Targets

A number of brokerages have recently commented on CBT. Truist Financial set a $100.00 price target on Cabot in a research note on Wednesday, August 5th. Mizuho boosted their price objective on Cabot from $80.00 to $90.00 and gave the company a “neutral” rating in a research report on Thursday, June 25th. Wall Street Zen upgraded Cabot from a “hold” rating to a “buy” rating in a report on Sunday, August 9th. Weiss Ratings reiterated a “hold (c)” rating on shares of Cabot in a report on Friday. Finally, JPMorgan Chase & Co. lifted their target price on Cabot from $70.00 to $78.00 and gave the company an “underweight” rating in a research report on Friday, August 7th. Two research analysts have rated the stock with a Buy rating, four have assigned a Hold rating and one has issued a Sell rating to the stock. According to MarketBeat.com, the company presently has an average rating of “Hold” and an average price target of $89.00.

Institutional Inflows and Outflows

Institutional investors have recently made changes to their positions in the business. Torren Management LLC bought a new position in shares of Cabot in the fourth quarter valued at about $26,000. Rothschild Investment LLC increased its holdings in Cabot by 170.4% in the 4th quarter. Rothschild Investment LLC now owns 411 shares of the specialty chemicals company’s stock valued at $27,000 after buying an additional 259 shares during the period. Northwestern Mutual Wealth Management Co. acquired a new position in shares of Cabot in the 2nd quarter valued at approximately $33,000. Global Retirement Partners LLC raised its position in shares of Cabot by 1,606.9% in the 4th quarter. Global Retirement Partners LLC now owns 495 shares of the specialty chemicals company’s stock valued at $33,000 after buying an additional 466 shares in the last quarter. Finally, Geneos Wealth Management Inc. lifted its holdings in shares of Cabot by 409.0% during the 1st quarter. Geneos Wealth Management Inc. now owns 453 shares of the specialty chemicals company’s stock worth $38,000 after acquiring an additional 364 shares during the period. 93.18% of the stock is owned by institutional investors and hedge funds.

Cabot Company Profile

Cabot Corporation is a global specialty chemicals and performance materials company headquartered in Boston, Massachusetts. Founded in 1882 by Godfrey Lowell Cabot, the company has grown into a diversified manufacturer with operations across North America, Europe, Asia and Latin America. Cabot serves a wide range of end markets, including automotive, industrial, energy, and consumer products, supplying essential ingredients that enhance performance, durability and functionality.

The company operates two primary segments: Reinforcement Materials and Performance Materials.